撤稿：二氢嘧啶脱氢酶（DPYD）基因多态性对结直肠癌患者5-氟尿嘧啶毒性的影响：一项荟萃分析。
Retracted: Influence of DPYD Genetic Polymorphisms on 5-Fluorouracil Toxicities in Patients with Colorectal Cancer: A Meta-Analysis.
作者信息
Research And Practice Gastroenterology
出版信息
Gastroenterol Res Pract. 2020 Nov 14;2020:9470819. doi: 10.1155/2020/9470819. eCollection 2020.
Abstract
[This retracts the article DOI: 10.1155/2014/827989.].
摘要
[本文撤回文章DOI：10.1155/2014/827989。]
相似文献
1
Retracted: Influence of DPYD Genetic Polymorphisms on 5-Fluorouracil Toxicities in Patients with Colorectal Cancer: A Meta-Analysis.撤稿：二氢嘧啶脱氢酶（DPYD）基因多态性对结直肠癌患者5-氟尿嘧啶毒性的影响：一项荟萃分析。
Gastroenterol Res Pract. 2020 Nov 14;2020:9470819. doi: 10.1155/2020/9470819. eCollection 2020.
2
Influence of DPYD Genetic Polymorphisms on 5-Fluorouracil Toxicities in Patients with Colorectal Cancer: A Meta-Analysis.DPYD基因多态性对结直肠癌患者5-氟尿嘧啶毒性的影响：一项荟萃分析
Gastroenterol Res Pract. 2014;2014:827989. doi: 10.1155/2014/827989. Epub 2014 Dec 28.
3
Investigation of , and polymorphisms on 5-fluorouracil related toxicities in colorectal cancer.探讨 5-氟尿嘧啶相关毒性的 、 和 多态性在结直肠癌中的作用。
Per Med. 2022 Sep;19(5):435-444. doi: 10.2217/pme-2021-0047. Epub 2022 Jul 26.
4
Influence of DPYD*9A, DPYD*6 and GSTP1 ile105val Genetic Polymorphisms on Capecitabine and Oxaliplatin (CAPOX) Associated Toxicities in Colorectal Cancer (CRC) Patients.DPYD*9A、DPYD*6和GSTP1 ile105val基因多态性对结直肠癌（CRC）患者卡培他滨和奥沙利铂（CAPOX）相关毒性的影响
Asian Pac J Cancer Prev. 2019 Oct 1;20(10):3093-3100. doi: 10.31557/APJCP.2019.20.10.3093.
5
DPYD*2A and MTHFR C677T predict toxicity and efficacy, respectively, in patients on chemotherapy with 5-fluorouracil for colorectal cancer.DPYD*2A 和 MTHFR C677T 分别预测结直肠癌患者接受氟尿嘧啶化疗的毒性和疗效。
Cancer Chemother Pharmacol. 2018 Jan;81(1):119-129. doi: 10.1007/s00280-017-3478-3. Epub 2017 Nov 13.
6
Predictive value of clinical toxicities of chemotherapy with fluoropyrimidines and oxaliplatin in colorectal cancer by DPYD and GSTP1 gene polymorphisms.DPYD和GSTP1基因多态性对氟嘧啶和奥沙利铂化疗在结直肠癌中临床毒性的预测价值
World J Surg Oncol. 2020 Dec 6;18(1):321. doi: 10.1186/s12957-020-02103-3.
7
Thymidylate synthase (TYMS) and dihydropyrimidine dehydrogenase (DPYD) polymorphisms in the Korean population for prediction of 5-fluorouracil-associated toxicity.韩国人群中胸苷酸合成酶（TYMS）和二氢嘧啶脱氢酶（DPYD）基因多态性对预测5-氟尿嘧啶相关毒性的研究
Ther Drug Monit. 2007 Apr;29(2):190-6. doi: 10.1097/FTD.0b013e318040b1fe.
8
Genetic influence of polymorphism on plasma levels of 5-fluorouracil and subsequent toxicity after oral administration of capecitabine in colorectal cancer patients of South Indian origin.5-氟尿嘧啶在印度南方起源的结直肠癌患者口服卡培他滨后的血药浓度及其随后毒性的多态性的遗传影响。
Drug Metab Pers Ther. 2020 Sep 23;35(4):/j/dmdi.ahead-of-print/dmdi-2020-0133/dmdi-2020-0133.xml. doi: 10.1515/dmpt-2020-0133.
9
Potential of dihydropyrimidine dehydrogenase genotypes in personalizing 5-fluorouracil therapy among colorectal cancer patients.二氢嘧啶脱氢酶基因型在结直肠癌患者氟尿嘧啶个体化治疗中的潜力。
Ther Drug Monit. 2013 Oct;35(5):624-30. doi: 10.1097/FTD.0b013e318290acd2.
10
and polymorphisms as predictors of 5 fluorouracil toxicity in colorectal cancer patients.以及多态性作为预测结直肠癌患者氟尿嘧啶毒性的标志物。
J Chemother. 2023 Sep;35(5):425-434. doi: 10.1080/1120009X.2022.2125736. Epub 2022 Sep 22.
本文引用的文献
1
Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis.卡培他滨和其他基于氟尿嘧啶的方案的毒性遗传标志物：QUASAR2 研究的调查、系统评价和荟萃分析。
J Clin Oncol. 2014 Apr 1;32(10):1031-9. doi: 10.1200/JCO.2013.51.1857. Epub 2014 Mar 3.
2
DPYD IVS14+1G>A and 2846A>T genotyping for the prediction of severe fluoropyrimidine-related toxicity: a meta-analysis.DPYD IVS14+1G＞A 和 2846A＞T 基因分型预测严重氟尿嘧啶相关毒性的荟萃分析。
Pharmacogenomics. 2013 Aug;14(11):1255-72. doi: 10.2217/pgs.13.116.
Zotero 插件